NCT03028532View on ClinicalTrials.gov

Administration of Clomiphene: Short and Long Term Metabolism in an Anti-Doping Setting

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 13, 2017

Primary Completion Date

January 25, 2018

Study Completion Date

October 15, 2018

Conditions
Sports Drug AbuseAbuse of Steroids or Hormones
Interventions
DRUG

Clomid

Participants will self-administer Clomid (50mg oral tablet) once daily for 30 consecutive days

Trial Locations (1)

84124

Heidi Jo Hansen, Salt Lake City

All Listed Sponsors
collaborator

Sports Medicine Research and Testing Laboratory

INDUSTRY

collaborator

Partnership for Clean Competition

OTHER

lead

Stuart Willick

OTHER

NCT03028532 - Administration of Clomiphene: Short and Long Term Metabolism in an Anti-Doping Setting | Biotech Hunter | Biotech Hunter